| 價(jià)格 | ¥13800 | ¥17500 |
| 包裝 | 50mg | 100mg |
| 最小起訂量 | 50mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-07-15 |
| 中文名稱:化合物 A-317491 sodium salt hydrate | 英文名稱:A-317491 sodium salt hydrate |
| 品牌: TargetMol | 產(chǎn)地: 美國 |
| 保存條件: Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | 產(chǎn)品類別: 抑制劑 |
| 貨號(hào): T001|T10204 |
| 名稱 | A-317491 sodium salt hydrate |
| 描述 | A-317491 sodium salt hydrate is a non-nucleotide P2X3 and P2X2/3 receptor antagonist that inhibits receptor-mediated calcium flux. |
| 體外活性 | A-317491 is known that P2X3 and P2X2/3 receptors stimulate the pronociceptive effects of ATP upon activation. Studies indicate that the P2X3 receptor is implicated in both neuropathic and inflammatory pain. The P2X3 receptor is a promising target for therapeutic intervention in cancer patients for pain management. |
| 存儲(chǔ)條件 | Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 100 mg/mL (164.86 mM), Sonication is recommended. H2O : 100 mg/mL (164.86 mM), Sonication is recommended. |
| 關(guān)鍵字 | A317491 sodium salt hydrate | A-317491 sodium Hydrate | A 317491 sodium salt hydrate | 475205-49-3 free base | 475205-49-3 |
| 相關(guān)產(chǎn)品 | Oxatomide | Lappaconitine | (E/Z)-Sivopixant | NP-1815-PX | ATP disodium salt | Gefapixant citrate | PSB-12062 | Ivermectin | Eperisone hydrochloride | Paroxetine | Sodium metatungstate | Aurintricarboxylic acid |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 589.8595萬人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
上海嘉定區(qū)澄瀏公路52號(hào)
|
2025-11-06 | ||
| 詢價(jià) |
VIP1年
|
陜西締都醫(yī)藥有限責(zé)任公司
|
2026-07-27 | |
| 詢價(jià) |
VIP5年
|
武漢艾美捷科技有限公司
|
2026-07-27 |